---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-040219"
form_type: "8-K"
ticker: "OSRH"
cik: "0001840425"
company_name: "OSR Holdings, Inc."
filed_at: "2023-02-15T23:59:59+00:00"
generated_at: "2026-06-19T11:57:09.732360+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# SPAC Bellevue Life Sciences closes $60M IPO; $61.05M in trust, 9-month deadline for healthcare deal

## Summary
- IPO of 6,000,000 units at $10/unit raises $60M; each unit comprises one share, one warrant ($11.50 strike), and one right (1/10 share).
- Private placement of 430,000 units to sponsor Bellevue Global Life Sciences Investors LLC raises additional $4.3M.
- Total $61.05M deposited into trust account; funds not released until business combination, amendment vote, or liquidation within 9 months.
- Units trade on Nasdaq under BLACU; common stock, warrants, and rights to trade separately under BLAC, BLACW, and BLACR.
- Company intends to focus on healthcare industry targets for its initial business combination.

## SEC filing metadata
- accession: 0001193125-23-040219
- form_type: 8-K
- ticker: OSRH
- cik: 0001840425
- company_name: OSR Holdings, Inc.
- filed_at: 2023-02-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840425/000119312523040219/0001193125-23-040219-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840425/000119312523040219/d466095d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-040219
- JSON: https://secwatch.observer/filing/0001193125-23-040219.json
- Plain text: https://secwatch.observer/filing/0001193125-23-040219.txt

## Key facts
- Governance Changes
  OSR Holdings, Inc.: Filed Amended and Restated Certificate of Incorporation on February 13, 2023 (effective 2023-02-13).
  - Change: charter amendment
  - Effective: 2023-02-13
  source text: On February 13, 2023, the Company filed an Amended and Restated Certificate of Incorporation with the Secretary of the State of Delaware.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840425/000119312523040219/0001193125-23-040219-index.htm
- Material Agreements
  OSR Holdings, Inc. entered into Underwriting Agreement with Chardan Capital Markets, LLC valued at $60.0 million (effective 2023-02-09).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Chardan Capital Markets, LLC
  - Value: $60.0 million
  - Effective: 2023-02-09
  source text: On February 9, 2023, Bellevue Life Sciences Acquisition Corp., a Delaware corporation (the “Company”), entered into an underwriting agreement by and between the Company and Chardan Capital Markets, LLC (“Chardan”), as representative of the several underwriters named therein (collectively, the “Underwriters”), a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by reference (the “Underwriting Agreement”), relating to the Company’s initial public offering (the “Offering”) of 6,000,000 units (the “Units”) at a price to the public of $10.00 per Unit.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840425/000119312523040219/0001193125-23-040219-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.